Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of POINT Biopharma Global Inc. from Q2 2023 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
POINT Biopharma Global Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q2 2023 to Q3 2023.
  • POINT Biopharma Global Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2023 was $2.39M.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

POINT Biopharma Global Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.39M 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $30.6K 30 Jun 2023 10-Q 14 Aug 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.